What is Elevance Health Inc Annual Revenue?

Elevance Health Inc Annual Revenue rose 3.19%, in the last year to $176,810 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

What is Elevance Health Inc Annual Net Profit?

Elevance Health Inc Annual Net Profit fell 0.12% in the last year to $5,980 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

What is Elevance Health Inc Price to Earning Ratio?

Elevance Health Inc Price to Earning Ratio is 15.43, lower than its sector PE ratio of 22.77.

What is Elevance Health Inc Stock Price?

Elevance Health Inc Stock Price fell 23.31% and underperformed its sector by 23.58% in the past year.

What is Elevance Health Inc Quarterly Revenue?

Elevance Health Inc Quarterly Revenue rose 6.55% YoY to $45,442 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

What is Elevance Health Inc Quarterly Net profit?

Elevance Health Inc Quarterly Net profit fell 51.17% YoY to $418 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

What is Elevance Health Inc Debt to Equity Ratio?

Elevance Health Inc Debt to Equity Ratio of 0.76 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Elevance Health Inc Return on Equity(ROE)?

Elevance Health Inc Return on Equity(ROE) for the last financial year was 14.83%, in the normal range of 10% to 20%.

What is Elevance Health Inc Mutual Fund Holding?

Elevance Health Inc Mutual Fund Holding increased by 1.1% in the last quarter to 92.06.

What is Elevance Health Inc Promoter Share Holding?

Elevance Health Inc Promoter Share Holding increased by 0.01% in the most recent quarter to 0.15%.

What is Elevance Health Inc Interest Coverage Ratio?

Elevance Health Inc Interest Coverage Ratio is 7.67, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Elevance Health Inc Institutional Holding?

Elevance Health Inc Institutional Holding increased by 0.59% in the last quarter to 92.77.

How is the Elevance Health Inc today?

The Elevance Health Inc today is trading in the down by -4.00% at 407.53.

How has Elevance Health Inc performed historically?

The Elevance Health Inc is currently trading down -4.00% on an intraday basis in the past week the index fell -7.34%. The index has been up 5.77% in the past quarter and fell -23.31% in the past year. You can view this in the overview section.

Elevance Health Inc XNYS: ELV

Elevance Health Inc Live Share Price Today, Share Analysis and Chart

Name: Elevance Health Inc: Is Infosys Ltd. worth buying?
Item: Elevance Health Inc
Rating: 1.892624875
Author: Trendlyne DVM scores

Await Turnaround

Download real time

407.53 -17.00 (-4.00%)

28.16% Fall from 52W High

609.9K XNYS Volume

XNYS 21 Apr, 2025 11:39 AM (EDT)

Board Meeting

The next board meeting for Elevance Health Inc is on 22 Apr 2025 for the purpose of Elevance Health Inc First Quarter Earnings Conference Call for 2025 See details

Elevance Health Inc Key Metrics

My Metrics

Default

Market Capitalization Market Runner Up Unavailable in chosen country	92,259.5
PE TTM Below industry Median Unavailable in chosen country	15.4
PEG TTM Negative PEG TTM Unavailable in chosen country	-132
Price to Book Below industry Median Unavailable in chosen country	2.2
Institutional holding current Qtr % Below industry Median Unavailable in chosen country	92.8
Revenue Growth Qtr YoY % Below industry Median Unavailable in chosen country	6.6
Operating Revenue growth TTM % Low in industry Unavailable in chosen country	3.2
Net Profit Qtr Growth YoY % Negative Net Profit Qtr Growth YoY % Unavailable in chosen country	-51.2
Net Profit TTM Growth % Negative Net Profit TTM Growth % Unavailable in chosen country	-0.1
Piotroski Score Low in industry Unavailable in chosen country	2
Rel Perf vs Sector quarter% Unavailable in chosen country	16.9
ROE Annual % Market Runner Up Unavailable in chosen country	14.8
RoA Annual % Market Runner Up Unavailable in chosen country	5.3

All financials are in USD Million and price data in USD

Low Financial Strength

33.3 / 100

Mid Valuation

38.8 / 100

Technically Neutral

45.9 / 100

Await Turnaround These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks. View Similar Embed DVM

501

1Yr Price target upside is 23%

19 analysts

Check Before You Buy

Check P/E Buy Sell Zone

Neutral Zone

59.0 % into P/E buy sell zone

Strong upside potential

% time spent below current P/E

Gains already realized

Elevance Health Inc Stock Price Analysis

Day Price Range -4.0% 1 Day return Unavailable in chosen country	407.5 (LTP) 407.2422.4 LowHigh
Week Price Range -7.3% 1 Week return Unavailable in chosen country	407.5 (LTP) 390443.3 LowHigh
Month Price Range -6.2% 1 Month return Unavailable in chosen country	407.5 (LTP) 390458.8 LowHigh
52 Week Price Range -23.3% 1 Year return Unavailable in chosen country	407.5 (LTP) 362.2567.3 LowHigh

View full Share Price History

Elevance Health Inc Live Price Chart

Switch to TradingView

Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Hit

Elevance Health Inc's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

QUARTER
ANNUAL

Current EPS

25.7

Avg. Estimate

Low Estimate

28.4

High Estimate

32.4

Current EPS

Avg. Estimate

Hit

EPS is expected to grow by 20.8% in FY25

Consensus Recommendation

22 ANALYST Recommendations

BUY

The consensus recommendation from 22 analysts for Elevance Health Inc is BUY

Forecaster is a Premium Feature

You need to upgrade your subscription plan to access this feature

Upgrade Now

Elevance Health Inc Stock Analysis

Elevance Health Inc stock analysis with key metrics, changes, and trends.

Elevance Health Inc Metric	VALUE	CHANGE %	TREND	ANALYSIS
Annual Revenue	$176,810 M	3.19%	positive	Annual Revenue rose 3.19%, in the last year to $176,810 M. Its sector's average revenue growth for the last fiscal year was 8.12%.
Annual Net Profit	$5,980 M	0.12%	negative	Annual Net Profit fell 0.12% in the last year to $5,980 M. Its sector's average net profit growth for the last fiscal year was 3.53%.
Price to Earning Ratio	15.43	-	positive	Price to Earning Ratio is 15.43, lower than its sector PE ratio of 22.77.
Stock Price	$407.53	-23.31%	negative	Stock Price fell 23.31% and underperformed its sector by 23.58% in the past year.
Quarterly Revenue	$45,442 M	6.55%	positive	Quarterly Revenue rose 6.55% YoY to $45,442 M. Its sector's average revenue growth YoY for the quarter was 9.6%.
Quarterly Net profit	$418 M	51.17%	negative	Quarterly Net profit fell 51.17% YoY to $418 M. Its sector's average net profit growth YoY for the quarter was 36.99%.
Debt to Equity Ratio	0.76	-	positive	Debt to Equity Ratio of 0.76 is less than 1 and healthy. This implies that its assets are financed mainly through equity.
Return on Equity(ROE)	14.83 %	14.83%	neutral	Return on Equity(ROE) for the last financial year was 14.83%, in the normal range of 10% to 20%.
Mutual Fund Holding	92.06 %	1.1%	positive	Mutual Fund Holding increased by 1.1% in the last quarter to 92.06.
Promoter Share Holding	0.15 %	0.01%	positive	Promoter Share Holding increased by 0.01% in the most recent quarter to 0.15%.
Interest Coverage Ratio	7.67	-	positive	Interest Coverage Ratio is 7.67, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).
Institutional Holding	92.77 %	0.59%	positive	Institutional Holding increased by 0.59% in the last quarter to 92.77.

VIEW LESS

Loading data..

Elevance Health Inc - Company Profile

What does Elevance Health Inc do?

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

2024

Gross Remuneration

Year

Elevance Health Inc Live Share Price Today, Share Analysis and Chart

28.16% Fall from 52W High

Elevance Health Inc Key Metrics

Market Capitalization

PE TTM

PEG TTM

RoA Annual %

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

Market Capitalization

PE TTM

PEG TTM

Price to Book

Institutional holding current Qtr %

Revenue Growth Qtr YoY %

Operating Revenue growth TTM %

Net Profit Qtr Growth YoY %

Net Profit TTM Growth %

Piotroski Score

Rel Perf vs Sector quarter%

ROE Annual %

RoA Annual %

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Elevance Health Inc Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Elevance Health Inc Live Price Chart

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Elevance Health Inc's Revenue was higher than average estimate 2 times in past 3 years

EPS forecast

EPS is expected to grow by 20.8% in FY25

Consensus Recommendation

The consensus recommendation from 22 analysts for Elevance Health Inc is BUY

Elevance Health Inc Stock Analysis

Elevance Health Inc stock analysis with key metrics, changes, and trends.

Annual Revenue rose 3.19%, in the last year to $176,810 M. Its sector's average revenue growth for the last fiscal year was 8.12%.

Annual Net Profit fell 0.12% in the last year to $5,980 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio is 15.43, lower than its sector PE ratio of 22.77.

Stock Price fell 23.31% and underperformed its sector by 23.58% in the past year.

Quarterly Revenue rose 6.55% YoY to $45,442 M. Its sector's average revenue growth YoY for the quarter was 9.6%.

Quarterly Net profit fell 51.17% YoY to $418 M. Its sector's average net profit growth YoY for the quarter was 36.99%.

Debt to Equity Ratio of 0.76 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE) for the last financial year was 14.83%, in the normal range of 10% to 20%.

Mutual Fund Holding increased by 1.1% in the last quarter to 92.06.

Promoter Share Holding increased by 0.01% in the most recent quarter to 0.15%.

Interest Coverage Ratio is 7.67, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding increased by 0.59% in the last quarter to 92.77.

Elevance Health Inc - Company Profile

What does Elevance Health Inc do?

Elevance Health Inc Management structure

Ms. Gail Koziara Boudreaux

President, Chief Executive Officer and Director

Mr. Mark B. Kaye

Executive Vice President and Chief Financial Officer

Mr. Peter D. Haytaian

Executive Vice President; President of Carelon and CarelonRx

Ms. Felicia F Norwood

Executive Vice President and President, Government Health Benefits

Mr. Charles Morgan Kendrick, Jr

Executive Vice President and President, Commercial and Specialty Health Benefits

Mr. Blair W. Todt

Executive Vice President and Chief Legal and Administrative Officer

Elevance Health Inc Board of directors

Ms. Elizabeth E. Tallett

Chairman of the Board

Mr. Ramiro G. Peru

Independent Director

Dr. Bahija Jallal, PhD